Technology of mammalian cell encapsulation

被引:443
作者
Uludag, H
De Vos, P
Tresco, PA
机构
[1] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G3, Canada
[2] Univ Groningen Hosp, Surg Res Lab, NL-9713 BZ Groningen, Netherlands
[3] Univ Utah, Dept Bioengn, Keck Ctr Tissue Engn, Salt Lake City, UT 84112 USA
关键词
cells; encapsulation; micro; macro; encapsulation technology; alginate-polylysine capsules; thermoreversible gelation;
D O I
10.1016/S0169-409X(00)00053-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Entrapment of mammalian cells in physical membranes has been practiced since the early 1950s when it was originally introduced as a basic research tool. The method has since been developed based on the promise of its therapeutic usefulness in tissue transplantation. Encapsulation physically isolates a cell mass from an outside environment and aims to maintain normal cellular physiology within a desired permeability barrier. Numerous encapsulation techniques have been developed over the years. These techniques are generally classified as microencapsulation (involving small spherical vehicles and conformally coated tissues) and macroencapsulation (involving larger hat sheet and hollow-fiber membranes). This review is intended to summarize techniques of cell encapsulation as well as methods for evaluating the performance of encapsulated cells. The techniques reviewed include microencapsulation with polyelectrolyte complexation emphasizing alginate-polylysine capsules, thermoreversible gelation with agarose as a prototype system, interfacial precipitation and interfacial polymerization, as well as the technology of flat sheet and hollow fiber-based macroencapsulation. Four aspects of encapsulated cells that are critical for the success of the technology, namely the capsule permeability, mechanical properties, immune protection and biocompatibility, have been singled out and methods to evaluate these properties were summarized. Finally, speculations regarding future directions of cell encapsulation research and device development are included from the authors' perspective. (C) 2000 Published by Elsevier Science B.V.
引用
收藏
页码:29 / 64
页数:36
相关论文
共 279 条
[1]   TRANSPLANTATION OF POLYMER ENCAPSULATED NEUROTRANSMITTER SECRETING CELLS - EFFECT OF THE ENCAPSULATION TECHNIQUE [J].
AEBISCHER, P ;
WINN, SR ;
TRESCO, PA ;
JAEGER, CB ;
GREENE, LA .
JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME, 1991, 113 (02) :178-183
[2]   LONG-TERM CROSS-SPECIES BRAIN TRANSPLANTATION OF A POLYMER-ENCAPSULATED DOPAMINE-SECRETING CELL-LINE [J].
AEBISCHER, P ;
TRESCO, PA ;
WINN, SR ;
GREENE, LA ;
JAEGER, CB .
EXPERIMENTAL NEUROLOGY, 1991, 111 (03) :269-275
[3]   Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients [J].
Aebischer, P ;
Schluep, M ;
Deglon, N ;
Joseph, JM ;
Hirt, L ;
Heyd, B ;
Goddard, M ;
Hammang, JP ;
Zurn, AD ;
Kato, AC ;
Regli, F ;
Baetge, EE .
NATURE MEDICINE, 1996, 2 (06) :696-699
[4]   TRANSPLANTATION IN HUMANS OF ENCAPSULATED XENOGENEIC CELLS WITHOUT IMMUNOSUPPRESSION - A PRELIMINARY-REPORT [J].
AEBISCHER, P ;
BUCHSER, E ;
JOSEPH, JM ;
FAVRE, J ;
DETRIBOLET, N ;
LYSAGHT, M ;
RUDNICK, S ;
GODDARD, M .
TRANSPLANTATION, 1994, 58 (11) :1275-1277
[5]   MACROENCAPSULATION OF DOPAMINE-SECRETING CELLS BY COEXTRUSION WITH AN ORGANIC POLYMER-SOLUTION [J].
AEBISCHER, P ;
WAHLBERG, L ;
TRESCO, PA ;
WINN, SR .
BIOMATERIALS, 1991, 12 (01) :50-56
[6]   FUNCTIONAL RECOVERY IN HEMIPARKINSONIAN PRIMATES TRANSPLANTED WITH POLYMER-ENCAPSULATED PC12 CELLS [J].
AEBISCHER, P ;
GODDARD, M ;
SIGNORE, AP ;
TIMPSON, RL .
EXPERIMENTAL NEUROLOGY, 1994, 126 (02) :151-158
[7]   TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS USING A GENE-THERAPY APPROACH [J].
AEBISCHER, P ;
KATO, AC .
EUROPEAN NEUROLOGY, 1995, 35 (02) :65-68
[8]  
AEBISCHER P, 1999, PARTICULATE NONCROSS
[9]  
AEBISCHER P, 1993, FUNDAMENTALS ANIMAL
[10]  
AEBISCHER P, 1986, T AM SOC ART INT ORG, V32, P134